These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 33910206)

  • 1. Empowering Muscle Stem Cells for the Treatment of Duchenne Muscular Dystrophy.
    Filippelli RL; Chang NC
    Cells Tissues Organs; 2022; 211(6):641-654. PubMed ID: 33910206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Satellite Cells in Muscular Dystrophy - Lost in Polarity.
    Chang NC; Chevalier FP; Rudnicki MA
    Trends Mol Med; 2016 Jun; 22(6):479-496. PubMed ID: 27161598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myopathologic trajectory in Duchenne muscular dystrophy (DMD) reveals lack of regeneration due to senescence in satellite cells.
    Cardone N; Taglietti V; Baratto S; Kefi K; Periou B; Gitiaux C; Barnerias C; Lafuste P; Pharm FL; Pharm JN; Panicucci C; Desguerre I; Bruno C; Authier FJ; Fiorillo C; Relaix F; Malfatti E
    Acta Neuropathol Commun; 2023 Oct; 11(1):167. PubMed ID: 37858263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9-Based Dystrophin Restoration Reveals a Novel Role for Dystrophin in Bioenergetics and Stress Resistance of Muscle Progenitors.
    Matre PR; Mu X; Wu J; Danila D; Hall MA; Kolonin MG; Darabi R; Huard J
    Stem Cells; 2019 Dec; 37(12):1615-1628. PubMed ID: 31574188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.
    Siemionow M; Langa P; Harasymczuk M; Cwykiel J; Sielewicz M; Smieszek J; Heydemann A
    Stem Cells Transl Med; 2021 Oct; 10(10):1406-1418. PubMed ID: 34291884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Application of Extracellular Vesicles-Capsulated Adeno-Associated Virus Vector via
    Matsuzaka Y; Hirai Y; Hashido K; Okada T
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duchenne muscular dystrophy: pathogenesis and promising therapies.
    Chang M; Cai Y; Gao Z; Chen X; Liu B; Zhang C; Yu W; Cao Q; Shen Y; Yao X; Chen X; Sun H
    J Neurol; 2023 Aug; 270(8):3733-3749. PubMed ID: 37258941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Satellite cell contribution to disease pathology in Duchenne muscular dystrophy.
    Kodippili K; Rudnicki MA
    Front Physiol; 2023; 14():1180980. PubMed ID: 37324396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy.
    Sugihara H; Teramoto N; Nakamura K; Shiga T; Shirakawa T; Matsuo M; Ogasawara M; Nishino I; Matsuwaki T; Nishihara M; Yamanouchi K
    Sci Rep; 2020 Oct; 10(1):16385. PubMed ID: 33046751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting fibrosis in Duchenne muscular dystrophy.
    Zhou L; Lu H
    J Neuropathol Exp Neurol; 2010 Aug; 69(8):771-6. PubMed ID: 20613637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients.
    Meyer P; Notarnicola C; Meli AC; Matecki S; Hugon G; Salvador J; Khalil M; Féasson L; Cances C; Cottalorda J; Desguerre I; Cuisset JM; Sabouraud P; Lacampagne A; Chevassus H; Rivier F; Carnac G
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro.
    Vieira NM; Brandalise V; Zucconi E; Jazedje T; Secco M; Nunes VA; Strauss BE; Vainzof M; Zatz M
    Biol Cell; 2008 Apr; 100(4):231-41. PubMed ID: 17997718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric Cell Therapies as a Novel Approach for Duchenne Muscular Dystrophy (DMD) and Muscle Regeneration.
    Budzynska K; Siemionow M; Stawarz K; Chambily L; Siemionow K
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38785982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo gene editing of the dystrophin gene in muscle stem cells mediated by peptide nucleic acid single stranded oligodeoxynucleotides induces stable expression of dystrophin in a mouse model for Duchenne muscular dystrophy.
    Nik-Ahd F; Bertoni C
    Stem Cells; 2014 Jul; 32(7):1817-30. PubMed ID: 24753122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy.
    Rugowska A; Starosta A; Konieczny P
    Clin Epigenetics; 2021 Jan; 13(1):13. PubMed ID: 33468200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednisolone rescues Duchenne muscular dystrophy phenotypes in human pluripotent stem cell-derived skeletal muscle in vitro.
    Al Tanoury Z; Zimmerman JF; Rao J; Sieiro D; McNamara HM; Cherrier T; Rodríguez-delaRosa A; Hick-Colin A; Bousson F; Fugier-Schmucker C; Marchiano F; Habermann B; Chal J; Nesmith AP; Gapon S; Wagner E; Gupta VA; Bassel-Duby R; Olson EN; Cohen AE; Parker KK; Pourquié O
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34260377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
    Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
    Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the process of fibrosis in Duchenne muscular dystrophy.
    Kharraz Y; Guerra J; Pessina P; Serrano AL; Muñoz-Cánoves P
    Biomed Res Int; 2014; 2014():965631. PubMed ID: 24877152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.